<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>06931861105105</udiDi>
    <basicUdiDi>69318611ophtha0022K</basicUdiDi>
    <tradeName>Survisc®</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Shanghai Qisheng Biological Preparation Co., Ltd</manufacturerName>
    <manufacturerSrn>CN-PR-000048812</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>15mg/mL-0.4mL</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-31T15:51:13.071Z</lastUpdated>
  </row>
  <row>
    <udiDi>06931861105112</udiDi>
    <basicUdiDi>69318611ophtha0022K</basicUdiDi>
    <tradeName>Survisc®</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Shanghai Qisheng Biological Preparation Co., Ltd</manufacturerName>
    <manufacturerSrn>CN-PR-000048812</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>15mg/mL-0.55mL</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-09T18:29:24.862Z</lastUpdated>
  </row>
  <row>
    <udiDi>06931861105129</udiDi>
    <basicUdiDi>69318611ophtha0022K</basicUdiDi>
    <tradeName>Survisc®</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Shanghai Qisheng Biological Preparation Co., Ltd</manufacturerName>
    <manufacturerSrn>CN-PR-000048812</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>15mg/mL-0.85mL</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-09T18:29:24.824Z</lastUpdated>
  </row>
  <row>
    <udiDi>06931861105143</udiDi>
    <basicUdiDi>69318611ophtha0022K</basicUdiDi>
    <tradeName>Survisc®Plus</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Shanghai Qisheng Biological Preparation Co., Ltd</manufacturerName>
    <manufacturerSrn>CN-PR-000048812</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>20mg/mL-0.4mL</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-09T18:29:24.798Z</lastUpdated>
  </row>
  <row>
    <udiDi>06931861105150</udiDi>
    <basicUdiDi>69318611ophtha0022K</basicUdiDi>
    <tradeName>Survisc®Plus</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Shanghai Qisheng Biological Preparation Co., Ltd</manufacturerName>
    <manufacturerSrn>CN-PR-000048812</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>20mg/mL-0.55mL</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-09T18:29:24.772Z</lastUpdated>
  </row>
  <row>
    <udiDi>06931861105167</udiDi>
    <basicUdiDi>69318611ophtha0022K</basicUdiDi>
    <tradeName>Survisc®Plus</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Shanghai Qisheng Biological Preparation Co., Ltd</manufacturerName>
    <manufacturerSrn>CN-PR-000048812</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>20mg/mL-0.85mL</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-09T18:29:24.742Z</lastUpdated>
  </row>
  <row>
    <udiDi>06931861105174</udiDi>
    <basicUdiDi>69318611ophtha0022K</basicUdiDi>
    <tradeName>Survisc®Plus</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Shanghai Qisheng Biological Preparation Co., Ltd</manufacturerName>
    <manufacturerSrn>CN-PR-000048812</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>20mg/mL-1.0mL</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-09T18:29:24.709Z</lastUpdated>
  </row>
</eudamedExport>